Nivolumab and Ipilimumab

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Nivolumab and Ipilimumab
Treatment and conditionWhere it standsTrials
Nivolumab and Ipilimumab for squamous cell carcinoma of head and neckPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1